Skip to content

Study · Non-randomized trial · n = 46 · 2010

1 result

[Cortexin in the complex treatment of post stroke epilepsy].

Gafurov BG, Gafurov ShB

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2010

PMID20873481 (opens in a new tab)PepBankPUB-20873481

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with post-stroke epilepsy, adding cortexin enhanced clinical effects reflected by EEG changes versus basic therapy alone.

    In plain wordsIn patients with post-stroke epilepsy, adding cortexin improved clinical effects reflected by EEG changes versus basic therapy alone.

    Outcome
    IncreaseClinical response reflected by EEG changes
    Study

    n = 46

    Comparator
    basic therapy alone
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10 mg · intramuscular · 15 daysAs given in this study (human).

    Source sentences

    Summary
    The addition of cortexin to the complex treatment significantly enhanced clinical effects reflected by positive changes on EEG.
    3 context sentences
    Summary · context
    Forty-six patients with post stroke epilepsy were examined.
    Summary · context
    The basic treatment included depakine-chrono in the mean dosage of 750 mg per day, along with vascular drugs, Cortexin was used as an add-on therapy in 29 patients intramuscular in the dosage of 10 mg during 15 days.
    Summary · context
    Other 17 patients received only basic therapy.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.